Prof. Dr. med. Dirk Strumberg

Prof. Dr. med. Dirk Strumberg is a highly experienced doctor specializing in hematology and oncology. He currently serves as the Director of Hematology and Oncology at the prestigious Marien Hospital in Herne, Germany. With an impressive list of 113 scientific publications, Dr. Strumberg has made significant contributions to the field. His research includes a randomized phase II trial of the Polo-like kinase inhibitor BI 2536 for pancreatic cancer and the impact of gender on chemotherapy efficacy in Ewing sarcoma. Dr. Strumberg's expertise and commitment to advancing cancer treatment have earned him recognition and respect in the medical community. He is known for his dedication to patient care and his ability to provide innovative and personalized treatment plans. Patients under his care can rest assured that they are in capable hands, receiving the highest quality of care available.